Last update Dec. 4, 2020
An antimicrobial indicated in the treatment of leprosy.
Daily oral administration over several months.
It is excreted in breastmilk in an amount that could be significant (Venkatesan 1997), but no adverse effects have been observed in infants whose mothers were taking it, with the exception of being able to cause a reddish discoloration of the skin of infants, reversible at the end of treatment. (Ozturk 2017, WHO 2002).
May turn milk bright pink (Waters 1969).
Known alternatives with faster elimination and less excretion in breastmilk should be considered, especially during the neonatal period and in cases of prematurity.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM